Volume 85 Issue 22 | p. 18 | Concentrates
Issue Date: May 28, 2007

India's Sun Buying Israel's Taro Pharma

Department: Business

Sun Pharmaceutical Industries, a generic drugs maker in India, has agreed to acquire Israel-based Taro Pharmaceutical Industries in a $454 million deal. Sun had sales of $555 million in its last fiscal year, compared with $298 million for Taro. Sun is active in the U.S. through its Caraco subsidiary, while North America represents more than 90% of Taro's sales.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment